Remove 2024 Remove Manufacturing Remove Pharmaceutical
article thumbnail

Emerging Technologies in Pharmaceutical Manufacturing: Modular and Automated Platforms

Frost & Sullivan Manufacturing

In the ever-evolving landscape of pharmaceutical manufacturing, modular and automated platforms are spearheading a transformative shift, particularly in the realm of non-biologics. Digital Technologies: The integration of smart sensors and data analytics has streamlined manufacturing processes.

article thumbnail

Software Streamlines Pharmaceutical Development

Gary Mintchell

Global automation technology and software leader Emerson on April 16, 2024 introduced DeltaV Workflow Management, a next-generation software designed for life sciences companies in early-stage development. The post Software Streamlines Pharmaceutical Development appeared first on The Manufacturing Connection.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Milestone Pharmaceuticals makes changes to BOD

Canadian Manufacturing

MONTREAL and CHARLOTTE — Milestone Pharmaceuticals appoints Stuart Duty and Andrew Saik to its Board of Directors and will stand for election at the company’s 2024 Annual Meeting of Shareholders. Duty has experience in investment banking and operations primarily in the biotechnology and specialty pharmaceuticals sectors.

article thumbnail

Fusion Pharmaceuticals provides manufacturing update

Canadian Manufacturing

HAMILTON and BOSTON — Fusion Pharmaceuticals Inc., 4 that it has completed validation of its good manufacturing practice (GMP) manufacturing facility and produced the first clinical dose of a TAT. “We achieved alignment with the U.S. . “We achieved alignment with the U.S. ” Fusion reported on Jan.

article thumbnail

Cipher Pharmaceuticals acquires Natroba for $89.5M

Canadian Manufacturing

MISSISSAUGA — Cipher Pharmaceuticals acquires global product rights for Natroba (Spinosad) and the U.S. Cipher plans to seek Health Canada approval for Natroba later in 2024 and will commercialize the product in Canada through its existing dermatology infrastructure. commercial sales team from ParaPRO, in a deal valued at USD 89.5

article thumbnail

Pharma-manufacturer claims award for sustainable packaging

Manufacturer's Monthly

Image: Ego Pharmaceuticals Ego Pharmaceuticals has secured a Silver medal for Sustainable Packaging Design at the 2024 Australasian Packaging Innovation & Design (PIDA) Awards. Ego Pharmaceuticals’ efforts in revamping the QV Face range resulted in a significant leap in sustainability. per cent to 74.5

article thumbnail

Clarity Pharmaceuticals inks clinical supply agreement for prostate cancer imaging products

AU Manufacturing

ASX-listed Clarity Pharmaceuticals has signed a Master Service Agreement and a Clinical Supply Agreement with Siemens Healthineers company PETNET Solutions Inc for the supply expansion of Clarity’s 64Cu SAR-bisPSMA, a diagnostic radiopharmaceutical product for prostate cancer imaging. Billion during 2023,” Dr Taylor remarked.